Showing 38,481 - 38,500 results of 100,737 for search '(( 5 point decrease ) OR ( 5 ((wt decrease) OR (((mean decrease) OR (a decrease)))) ))', query time: 1.98s Refine Results
  1. 38481

    Image_2_Modification of Intestinal Microbiota Dysbiosis by Low-Dose Interleukin-2 in Dermatomyositis: A Post Hoc Analysis From a Clinical Trial Study.jpeg by Yunzhi Zhufeng (10961908)

    Published 2022
    “…Low-dose IL-2 treatment emerges as a new option for active IIMs. This study aims to explore the role of low-dose IL-2 in regulating intestinal dysbiosis involved in the IIMs. …”
  2. 38482
  3. 38483

    DataSheet_1_Identification and experimental validation of cuproptosis regulatory program in a sepsis immune microenvironment through a combination of single-cell and bulk RNA seque... by Tingru Zhao (17368789)

    Published 2024
    “…Patients with higher CuAS exhibited prominent strength and numbers of cell–cell interactions. A total of five CRGs were identified based on the LASSO and Cox regression analyses, and a CRG-based risk model was established. …”
  4. 38484

    Analysis of glycine and proliferation <i>in vitro</i> as a function of SHMT2 and sodium benzoate. by Jiefei Tong (426705)

    Published 2020
    “…Intracellular metabolites were extracted and analyzed by selected reaction monitoring mass spectrometry, SRM, n = 5 to 8 biological replicates. (A) In HeLa-Ss cells relative levels of intracellular glycine levels were measured as a function of endogenous SHMT2 expression (control; C) or elevated (+) or decreased (–) expression of SHTM2 (described above), and without (–) or with (+) glycine supplementation in growth medium. …”
  5. 38485
  6. 38486
  7. 38487

    GJIC has a dual effect on Cd-induced cytotoxic injury. by Hui Zou (666389)

    Published 2015
    “…<p><b>a</b>: Effect of Sal on the Cd-induced down-regulation of GJIC in BRL 3A cells and rat liver tissue(Cd 2.5 means 2.5μm Cd, Cd 10 means 10μm Cd). …”
  8. 38488
  9. 38489
  10. 38490

    Fluorofoldamer-Based Salt- and Proton-Rejecting Artificial Water Channels for Ultrafast Water Transport by Jie Shen (31533)

    Published 2022
    “…Produced by a facile one-pot copolymerization reaction under mild conditions, the best-performing channel (AWC <b>1</b>) is an n-C<sub>8</sub>H<sub>17</sub>-decorated foldamer nanotube with an average channel length of 2.8 nm and a pore diameter of 5.2 Å. …”
  11. 38491

    A–D: Meso scale networks Ba/F3-M351T. by Stefan Balabanov (104352)

    Published 2013
    “…<p>(<b>A</b>) Shows the protein expressions for wt and T351 cell type for all drugs. …”
  12. 38492

    Data. by Michael C. Payne (2664379)

    Published 2025
    “…The circulating filarial antigen (CFA) prevalence decreased from 46.4% at baseline (CI, 43.5-49.3%) to 29.5% (CI, 26.9-32.3%) after 40 months with yearly treatment and from 53.4% (CI, 51.0-55.9%) to 35.2% (CI, 32.7-37.8%) with semiannual MDA. …”
  13. 38493

    Multitarget-Directed Gallium(III) Tris(acyl-pyrazolonate) Complexes Induce Ferroptosis in Cancer Cells via Dysregulation of Cell Redox Homeostasis and Inhibition of the Mevalonate... by Daphne Romani (14658174)

    Published 2023
    “…A series of Ga­(Q<i><sub>n</sub></i>)<sub>3</sub> coordination compounds have been synthesized, where HQ<i><sub>n</sub></i> is 1-phenyl-3-methyl-4-RC­(O)-pyrazolo-5-one. …”
  14. 38494

    Multitarget-Directed Gallium(III) Tris(acyl-pyrazolonate) Complexes Induce Ferroptosis in Cancer Cells via Dysregulation of Cell Redox Homeostasis and Inhibition of the Mevalonate... by Daphne Romani (14658174)

    Published 2023
    “…A series of Ga­(Q<i><sub>n</sub></i>)<sub>3</sub> coordination compounds have been synthesized, where HQ<i><sub>n</sub></i> is 1-phenyl-3-methyl-4-RC­(O)-pyrazolo-5-one. …”
  15. 38495

    Multitarget-Directed Gallium(III) Tris(acyl-pyrazolonate) Complexes Induce Ferroptosis in Cancer Cells via Dysregulation of Cell Redox Homeostasis and Inhibition of the Mevalonate... by Daphne Romani (14658174)

    Published 2023
    “…A series of Ga­(Q<i><sub>n</sub></i>)<sub>3</sub> coordination compounds have been synthesized, where HQ<i><sub>n</sub></i> is 1-phenyl-3-methyl-4-RC­(O)-pyrazolo-5-one. …”
  16. 38496

    LC−MS/MS Analysis of Ovarian Cancer Metastasis-Related Proteins Using a Nude Mouse Model: 14-3-3 Zeta as a Candidate Biomarker by Yifeng He (563263)

    Published 2010
    “…Peritoneal implantation is the most common metastatic pattern of epithelial ovarian cancer, and the five-year survival rate of patients is dramatically decreased when large-scale peritoneal metastasis occurs. …”
  17. 38497

    LC−MS/MS Analysis of Ovarian Cancer Metastasis-Related Proteins Using a Nude Mouse Model: 14-3-3 Zeta as a Candidate Biomarker by Yifeng He (563263)

    Published 2010
    “…Peritoneal implantation is the most common metastatic pattern of epithelial ovarian cancer, and the five-year survival rate of patients is dramatically decreased when large-scale peritoneal metastasis occurs. …”
  18. 38498

    LC−MS/MS Analysis of Ovarian Cancer Metastasis-Related Proteins Using a Nude Mouse Model: 14-3-3 Zeta as a Candidate Biomarker by Yifeng He (563263)

    Published 2010
    “…Peritoneal implantation is the most common metastatic pattern of epithelial ovarian cancer, and the five-year survival rate of patients is dramatically decreased when large-scale peritoneal metastasis occurs. …”
  19. 38499

    LC−MS/MS Analysis of Ovarian Cancer Metastasis-Related Proteins Using a Nude Mouse Model: 14-3-3 Zeta as a Candidate Biomarker by Yifeng He (563263)

    Published 2010
    “…Peritoneal implantation is the most common metastatic pattern of epithelial ovarian cancer, and the five-year survival rate of patients is dramatically decreased when large-scale peritoneal metastasis occurs. …”
  20. 38500

    LC−MS/MS Analysis of Ovarian Cancer Metastasis-Related Proteins Using a Nude Mouse Model: 14-3-3 Zeta as a Candidate Biomarker by Yifeng He (563263)

    Published 2010
    “…Peritoneal implantation is the most common metastatic pattern of epithelial ovarian cancer, and the five-year survival rate of patients is dramatically decreased when large-scale peritoneal metastasis occurs. …”